Spruce Biosciences receives Nasdaq bid-price extension to April 21, 2025; moves to Capital Market

SPRUCE BIOSCIENCES, INC.

Received Nasdaq extension until April 21, 2025 to meet $1.00 minimum bid price.
Stock transfer from Nasdaq Global Select to Capital Market effective Oct 28, 2024.
Must maintain closing bid >=$1.00 for 10 consecutive business days before deadline.
May consider reverse stock split; failure to comply could lead to delisting.
No immediate impact on listing; company intends to monitor bid price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.